Introduction {#S0001}
============

In recent years, the widespread occurrence of extended-spectrum β-lactamases (ESBLs)-producing and carbapenem-resistant *Enterobacteriaceae* (CRE) in human clinic has renewed interest in the use of old antimicrobial agents, such as colistin and fosfomycin in the treatment of infections caused by multidrug-resistant pathogens.[@CIT0001]--[@CIT0003] Fosfomycin exhibits broad-spectrum bactericidal activity against Gram-positive and Gram-negative bacteria, and is listed as one of the first-line options for the treatment of uncomplicated lower urinary tract infections caused by ESBL-producing *Escherichia coli*.[@CIT0004],[@CIT0005]

Fosfomycin interferes with the biosynthesis of cell wall by inhibiting production of UDP-N-acetylglucosamine enolpyruvyl transferase (MurA).[@CIT0006] Besides, fosfomycin enters the bacterial cell via two transporters, glycerol-3-phosphate transporter (GlpT) and hexose phosphate transporter (UhpT).[@CIT0007],[@CIT0008] Several mechanisms underlying fosfomycin resistance have been identified in *E. coli*, including modification or overexpression of MurA, inactivation of transporters and their regulatory genes (such as *uhpA*, *cyaA*, and *ptsI*), and acquisition of fosfomycin-modifying enzymes.[@CIT0009] A variety of fosfomycin-modifying enzymes, such as FosA, FosB, FosC, FosL, have been described.[@CIT0010]--[@CIT0012] FosA is the most frequently reported group of enzymes in *Enterobacteriaceae*.[@CIT0012],[@CIT0013] As a glutathione S-transferase, FosA inactivates fosfomycin by catalyzing the addition of glutathione to fosfomycin.[@CIT0013] Until now, nine subtypes of fosA genes have been identified.[@CIT0010],[@CIT0012],[@CIT0014]-[@CIT0017] *fosA3*, the most widespread *fosA* gene in *E. coli*, has been detected in human and animal isolates from more than 12 countries, especially in food-producing animal-associated isolates from China.[@CIT0012],[@CIT0018]-[@CIT0020] All *fosA* subtypes, except *fosA2* and *fosA7*, are identified in plasmids, and they are usually originated from the chromosomal gene of *Enterobacteriaceae* species.[@CIT0014],[@CIT0016],[@CIT0017],[@CIT0021]-[@CIT0023]

In this study, we reported a novel plasmid-encoded *fosA* variant, *fosA10*, in an ESBL-producing *E. coli* isolate, and characterized the genetic context of *fosA10* to identify its origin.

Materials and Methods {#S0002}
=====================

Bacterial Isolation {#S0002-S2001}
-------------------

*E. coli* isolate PK9 was recovered from a local broiler meat outlet in Faisalabad, Pakistan, in March 2018 as previously described.[@CIT0024]

Antimicrobial Susceptibility Testing and Detection of *fos* Genes {#S0002-S2002}
-----------------------------------------------------------------

The MICs of 13 antimicrobial agents, including ampicillin, cefotaxime, ceftazidime, cefoxitin, florfenicol, streptomycin, doxycycline, ciprofloxacin, imipenem, colistin, amikacin, gentamycin, and tigecycline, were determined by either agar dilution or broth microdilution method (colistin and tigecycline) according to the Clinical Laboratory Standards Institute (CLSI) guideline.[@CIT0025] Besides, the agar dilution method using Mueller-Hinton agar supplemented with 25 μg/mL of glucose-6-phosphate (G6P) was applied to determine the fosfomycin MICs as recommended.[@CIT0025] *E. coli* ATCC 25922 was used as a quality control standard. The results were interpreted according to the breakpoints of the CLSI.[@CIT0025]

The presence of known *fos* genes (*fosA1* to *fosA7* and *fosC*) in PK9 was investigated by PCR amplification as previously described.[@CIT0014],[@CIT0015],[@CIT0022],[@CIT0023],[@CIT0026],[@CIT0027]

Whole-Genome Sequencing {#S0002-S2003}
-----------------------

Whole genomic DNA of the *fosA10*-positive *E. coli* isolate was extracted using HiPure Bacterial DNA Kit (Magen, Guangzhou, China). Whole-genome sequencing (WGS) was performed by Novogene (Beijing Novogene Bioinformatics Co., Ltd., Beijing, China) using Illumina HiSeq 2500 technology (Illumina, San Diego, CA, USA). De novo assembly was performed using SOAPdenovo (version 2.04). To obtain the complete sequence of the *fosA10*-carrying plasmid, we then sequenced *E. coli* PK9 on Oxford Nanopore MinION. The assemblies of long Nanopore reads and the short Illumina reads were combined via Unicycler (version 0.4.8). The resulting contigs were uploaded into the Center for Genomic Epidemiology server ([<https://cge.cbs.dtu.dk/services/>]{.ul}). The resistance genes, plasmid type, and multilocus sequence type (MLST) of PK9 were analyzed by ResFinder 3.2, PlasmidFinder, and MLST, respectively.

Conjugation Experiment {#S0002-S2004}
----------------------

Conjugation experiments were performed using isolate PK9 and *E. coli* strain C600 (high-level resistance to streptomycin) as donor and recipient strains, respectively.[@CIT0028] Transconjugants were selected on MacConkey agar plates containing fosfomycin (64 μg/mL) and streptomycin (3000 μg/mL) for counter-selection.

Cloning of *fosA10* Gene {#S0002-S2005}
------------------------

The *fosA10* gene from *E. coli* PK9 was cloned into the pMD19-T vector using primers listed as followed: PK9-F: 5ʹ-TCATTAGGGGATTCATCAGT-3ʹ and PK9-R: 5ʹ-AGATAGTGGAGCGGAGACC-3ʹ. Then, it was transferred into *E. coli* DH5α (Takara, Shiga, Japan) by heat shock. Transformants were selected on LB agar plates containing 100 μg/mL ampicillin. Recombinant clones were analyzed by PCR followed by Sanger sequencing.

Phylogenic Analyses and Homology Alignment {#S0002-S2006}
------------------------------------------

The amino acid sequence of FosA10 was predicted based on the nucleotide sequence of fosA10 gene, and its amino acid sequence was homologously aligned with the amino acid sequence of fosfomycin enzymes in other *Enterobacteriaceae* obtained from GenBank by T-Coffee.[@CIT0029],[@CIT0030] The phylogenic tree was constructed by distance method using Neighbor-Joining algorithm of MEGA 5. Branch lengths were drawn to scale and were proportional to the number of amino acid substitutions with 500 bootstrap replications.

Results and Discussion {#S0003}
======================

Identification of a Novel Plasmid-Mediated Fosfomycin Resistance Gene *fosA10* {#S0003-S2001}
------------------------------------------------------------------------------

*E. coli* PK9 was found to be resistant to ampicillin, cefotaxime, ceftazidime, cefoxitin, streptomycin, gentamycin, and ciprofloxacin, and intermediate to doxycycline ([Table 1](#T0001){ref-type="table"}). Notably, it was highly resistant to fosfomycin with an MIC \> 128 μg/mL ([Table 1](#T0001){ref-type="table"}). However, no *fosC2* or *fosA* gene (*fosA1*--*A7*) was detected from PK9 by PCR amplification. Conjugation experiment showed that the fosfomycin resistance of PK9 was transferred to the recipient *E. coli* C600 ([Table 1](#T0001){ref-type="table"}), indicating the presence of plasmid-mediated fosfomycin resistance gene.Table 1Antimicrobial Susceptibility of *fosA10*-Carrying *Escherichia coli* Strain PK9 and Transconjugant or TransformantStrain^a^PK9Transconjugant (*E. coli* C600 +pHNPK9-FOS)*E. coli* C600*E. coli* DH5α (pMD19-T +fosA10)*E. coli* DH5α (pMD19-T)Fosfomycin\>128\>1282\>1282Ampicillin\>12844\>128\>128Cefotaxime\>1280.030.1250.1250.06Ceftazidime\>1280.50.060.50.5Cefoxitin642422Streptomycin256\>256\>25622Gentamicin160.50.50.250.25Florfenicol42222Doxycycline80.250.50.250.25Ciprofloxacin640.0040.0080.0020.002Colistin0.250.1250.1250.1250.125Amikacin40.50.50.50.5Imipenem0.1250.50.1250.250.125Tigecycline0.250.250.250.250.25

WGS data showed that *E. coli* PK9 belonged to ST38. In a 1918 bp contig, a 420 bp open reading frame (ORF) encoding FosA-like protein was identified. This novel *fosA* gene was then named *fosA10* as the next available number according to published data and NCBI.[@CIT0017] *fosA10* had 69.7%, 67.8%, 73.4%, 73.1%, 98.3%, 99.3%, 58.2%, 64.0%, 93.9%, and 53.6% nucleotide identity with *fosA1* to *fosA9* and *fosC2*, respectively. Besides, the amino acid sequence of FosA10 enzyme encoded by *fosA10* shared 70.0%, 68.6%, 79.0%, 78.3%, 98.6%, 97.8%, 62.9%, 65.0%, 97.8%, and 56.1% identity with FosA1 to FosA9 and FosC2, respectively ([Figures 1](#F0001){ref-type="fig"} and [[S1](https://www.dovepress.com/get_supplementary_file.php?f=251360.docx)]{.ul}).Figure 1Phylogenetic tree obtained for the FosA proteins. The protein GenBank accession numbers are FosA^TN^(FosA1), AAA98399; FosA2, ACC85616; FosA3, AB522970; FosA4, AB908992; FosA5, AJE60855; FosA6, NG051497; FosA7, KKE03230; FosA8, CP013990; FosA9, PRJEB32329; and FosA10, MT074415.Figure 2Map of pHNPK9-FOS. The map was carried out by BLAST tools, Sequin (version 15.50), BLAST Ring Image Generator (BRIG, version 0.95), Serial Cloner (version 2.6.1), and SnapGene (version 4.1.9). The outermost two rings indicate the size and plasmid type of pHNPK9-FOS, respectively. The next ring shows features extracted from the genome GenBank file of pHNPK9-FOS. The next two rings show GC content and GC skew. Each is plotted as the deviation from the average for the entire sequence.

To determine whether *fosA10* could confer resistance to fosfomycin, we constructed a recombinant plasmid pMD19-T + fosA10. The MIC of fosfomycin for *E. coli* DH5α transformed with pMD19-T + fosA10 was \>128μg/mL, more than 64-fold higher than that of *E. coli* DH5α carrying pMD19-T alone ([Table 1](#T0001){ref-type="table"}).

Genetic Context and Origin of the *fosA10* Gene {#S0003-S2002}
-----------------------------------------------

Hybrid assembly of the MinION long reads and HiSeq short reads revealed that PK9 had a circular 5,423,354 bp chromosome and three plasmids ([Table 2](#T0002){ref-type="table"}). One plasmid, designated pHNPK9-FOS, carries *fosA10*. pHNPK9-FOS was a 53,736 bp plasmid containing 69 predicted ORFs, and belonged to IncFII (F35:A-:B-). It possessed a typical IncF-type backbone, encoding genes for replication, transfer, maintenance, and stability functions ([Figure 2](#F0002){ref-type="fig"}). A variable region of 4328 bp consisting of *fosA10* and two copies of IS*10* element was inserted into a hypothetical gene of the plasmid backbone. The insertion was surrounded by a 9-bp direct repeat sequences (DRs) (TACCTGGTG) suggesting mobilization of this *fosA10* gene by composite transposon formed by IS10 ([Figure 3](#F0003){ref-type="fig"}). In addition to *fosA10* gene, the region surrounded by IS*10* includes a truncated transcriptional regulator gene *lysR* (190 bp) and a 1060 bp sequence (containing a truncated hypothetical gene) located upstream and downstream of *fosA10*, respectively. BLAST homology analysis demonstrated that the sequence of the 1670 bp region surrounded by IS*10* had 100% nucleotide identity with chromosome sequences of 18 *K. pneumoniae* strains from Austria, USA, UK, Morocco, and Japan ([Figure 3](#F0003){ref-type="fig"} and [[Table S1](https://www.dovepress.com/get_supplementary_file.php?f=251360.docx)]{.ul}), suggesting its mobilization from the chromosome of one *K. pneumoniae* strain to plasmid. All the 18 *K. pneumoniae* strains belong to ST644 except one that belongs to ST3821 ([[Table S1](https://www.dovepress.com/get_supplementary_file.php?f=251360.docx)]{.ul}). In addition, a WGS contig (GenBank accession number MUJB01000052) of an *E. coli* strain AUH_IMP168 collected in 2013 from Lebanon also contained *fosA10* and two incomplete IS*10* elements caused by short-read DNA sequencing. The fragment containing *fosA10* surrounded by IS*10* in *E. coli* strain AUH_IMP168 was also 100% identical to the chromosome sequences of 18 *K. pneumoniae* strains mentioned above ([Figure 3](#F0003){ref-type="fig"}). However, the size of the spacer region between the 3ʹ end of *fosA10* and IS*10* was longer than that in pHNPK9-FOS (1663 bp vs 1060 bp), indicating occurrence of a different mobilization event of *fosA10* from *K. pneumoniae* chromosome.Table 2Resistance Genes and Plasmids Carried by *Escherichia coli* Strain PK9Chromosome or Plasmid NameReplicon of PlasmidSizeResistance GeneChromosomal Point MutationsChromosome--5,423,354 bp*mdf(A), aac(6ʹ)-Ib-cr, tet(A), dfrA1, aac(3)-IIa, aac(6ʹ)-Ib-cr, aadA1, aph(3ʹ')-Ib, aph(3ʹ')-Ib, aph(6)-Id, bla*~CMY-16~, *bla*~CTX-M-15~, *bla*~OXA-1~GyrA: S83L, D87N\
ParC: S80I, E84GpHNPK9-FOSIncFII (F35:A-:B-)53,736 bp*fosA10*-pHNPK9-2IncFII (F1:A-:B23)135,056 bpNone-pHNPK9-3Unknown97,203 bpNone- Figure 3Genetic structure surrounding the new *fosA10* gene, *fosA5*, and *fosA6* gene. Genes and ISs are indicated by bold arrows. DR sequences are represented by diagonal bars. 100% and 98%\~97% sequence identities were denoted by dark gray shading and light gray shading, respectively.

The other two plasmid-located *fosA* genes, *fosA5* and *fosA6*, also originated from *K. pneumoniae* chromosome,[@CIT0014],[@CIT0023] and have high similarity of nucleic acid sequence with *fosA10*, with difference in only four or seven nucleotides. Like *fosA10, lysR* genes truncated by IS*10* segment were identified upstream of *fosA5* (in plasmid pHKU1, GenBank accession number KC960485) and *fosA6* (in plasmid pYD786-2, KU254579.1),[@CIT0014],[@CIT0023],[@CIT0031] and the insertion sites of IS*10* upstream of *fosA5* and *fosA10* were the same ([Figure 3](#F0003){ref-type="fig"}). In addition, IS*10* was found to be inserted downstream of *fosA5*. However, the fragments located downstream of *fosA5, fosA6*, and *fosA10* were varied. Although *fosA5, fosA6*, and *fosA10* have significant homology and were all derived from the *K. pneumoniae* chromosome, these mobilization events of *fosA*^kp^ from the *K. pneumoniae* chromosome to plasmids seemed to occur separately. Nevertheless, the findings of several events of IS*10* insertion in *lysR* genes of *K. pneumoniae* in recent years implied that *lysR* gene was a hotspot for IS*10* insertion. Further capture of chromosomal *fosA* genes from *K. pneumoniae* by plasmids is possible.

In summary, we report the emergence of a novel plasmid-mediated *fosA* gene, *fosA10*, conferring high-level resistance to fosfomycin. *fosA10* gene was probably horizontally transferred from *K. pneumoniae* chromosome to *E. coli* plasmid by IS*10*. The increasing discovery of chromosomal *fosA* genes on plasmids is alarming and demonstrated that *Klebsiella spp*. might be an important reservoir of *fosA* genes for *E. coli*. Considering the apparent horizontal transferability of plasmids, further dissemination of these *fosA* genes among *E. coli* is possible and will constitute a serious threat to antimicrobial therapy. Therefore, we should pay more attention to the emergence and spread of plasmid-mediated *fosA* genes. Further studies on the occurrence and characterization of *fosA10*-carrying plasmids in *Enterobacteriaceae* from various sources (humans, animals, and the environment) will offer more insights into the potential role of *fosA10* in the dissemination of fosfomycin resistance.

The study was supported in part by grants from the National Natural Science Foundation of China (No. 31625026, 31830099). We would like to thank Zulqarnain Baloch for providing the strain.

Accession Number {#S0004}
================

The complete nucleotide sequence of plasmid pHNK9-FOS has been deposited in GenBank under accession no. MT074415.
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